Your session is about to expire
← Back to Search
Women with > 3 months amenorrhea for Hypogonadism (REVEAL Trial)
N/A
Recruiting
Led By Chrisandra Shufelt, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Summary
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Eligible Conditions
- Hypogonadism
- Hypothalamic Amenorrhea
- Amenorrhea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Study Participants
Secondary study objectives
Assessing the Impact of Amenorrhea on Women's Health: Symptoms, Care Experiences, and Work Productivity
Impact of Social, Early Life, and Pregnancy Factors on Functional Hypothalamic Amenorrhea
Trial Design
1Treatment groups
Experimental Treatment
Group I: Women with > 3 months amenorrheaExperimental Treatment2 Interventions
Women aged 18-40 years old with a diagnosis of functional hypothalamic amenorrhea, or lab results that are within the inclusion criteria.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,864,481 Total Patients Enrolled
1 Trials studying Hypogonadism
40 Patients Enrolled for Hypogonadism
Chrisandra Shufelt, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
119 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger